"We have tested the PIPL developed UVC disinfection unit, UV Suraxa® at Jahangir Hospital against few clinical strains of bacteria. The preliminary data analysis across all strains tested shows a consistent 3+ log (99.9%) reduction within 90 seconds of exposure in UV Suraxa."
"I have been pleased with UV Suraxa® performance, which I have been using for a month. customers to enable us with a safe start-up of Restaurant and Hotel."
"I am writing to confirm that I have worked with Pune Instrumentation’s Suraxa® UVC
device and found
that it inactivates over 99.99% of SARS-CoV-2 and H1N1 influenza A virus RNA within 2 minutes of
exposure at 54 Watt.
These inactivation efficiencies were obtained by adding viral RNA or live virus to plastic, cotton or
paper surfaces and
placing these surfaces in the device for the indicated time.
UVC inactivates RNA viruses by creating crosslinks and breaks in the viral RNA. We have used this principle and the Pune Instrumentation’s UVC device to create breaks in SARS-CoV-2 and H1N1 influenza A virus RNA. This inactivated viral RNA was then used to develop an RT-qPCR method that can distinguish between infectious and non-infectious viral RNA. The results of this study are available on MedRXiv under the title: “Reducing persistently positive SARS-CoV-2 diagnoses using long-range RT-qPCR”."
PIPL is a Custom Application Development company based in Pune, India.